MoranAmitMD

Physician

Dr. Amit is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Non-randomized, Open-label Study of Intralesional Nivolumab for High Risk Oral Premalignant Lesions Start of enrollment: 2022 Sep 13
Recruiting
Phase 1
Roles: Contact, Principal Investigator
Psilocybin-Assisted Psychotherapy in Patients With Advanced Cancer on Maintenance Therapy Start of enrollment: 2024 Apr 16
Recruiting
Phase 2
Roles: Contact, Principal Investigator

PubMed

Localized intratumoral delivery of immunomodulators for oral cancer and oral potentially malignant disorders.
Nourhan I Hussein, Andrea H Molina, Gemalene M Sunga, Moran Amit, Yu Leo Lei
Oral Oncology. 2024-11-01
Integrating priorities at the intersection of cancer and neuroscience.
William L Hwang, Ella N Perrault, Alexander Birbrair, Brandi J Mattson, David H Gutmann
Cancer Cell. 2024-10-15
1 citations
Targeting the peripheral neural-tumour microenvironment for cancer therapy.
Dan Yaniv, Brandi Mattson, Sebastien Talbot, Frederico O Gleber-Netto, Moran Amit
Nature Reviews. Drug Discovery. 2024-10-01

MD Anderson Research Highlights: ASCO 2024 Special EditionMay 23rd, 2024
Absent p53, Oral Cancers Reprogram Nerves to Fuel Tumor GrowthMarch 20th, 2020
Absent p53, Oral Cancers Recruit and Reprogram Nerves to Fuel Tumor GrowthFebruary 15th, 2020
Join now to see all